SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,697.02 402.06
( 0.54%)

Global Indices

Nasdaq

51,699.28 -99.76
(-0.19%)

Dow Jones

7,668.45 9.69
(0.13%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,654.81 -161.33
(-1.49%)

Forex

USD-INR

95.87 0.21
(0.22%)

EUR-INR

110.00 -0.22
(-0.20%)

GBP-INR

128.18 -0.44
(-0.35%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.6032787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

46.03

88.45

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

sanwaria consumer ltd

Astal Laboratories standalone net profit rises 77.51% in the June 2026 quarter

Aug 15,2026

Net profit of Astal Laboratories rose 77.51% to Rs 3.71 crore in the quarter ended June 2026 as against Rs 2.09 crore during the previous quarter ended June 2025. Sales rose 55.98% to Rs 39.51 crore in the quarter ended June 2026 as against Rs 25.33 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	39.51	25.33	56
OPM %	13.77	12.48	-
PBDT	5.14	2.92	76
PBT	4.96	2.80	77
NP	3.71	2.09	78

74,697.02 402.06 ( 0.54%)

51,699.28 -99.76 (-0.19%)

7,668.45 9.69 (0.13%)

65,040.24 903.99 (1.41%)

10,654.81 -161.33 (-1.49%)

95.87 0.21 (0.22%)

110.00 -0.22 (-0.20%)

128.18 -0.44 (-0.35%)

0.61 0.00 (-0.09%)